Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYTH

Cyclo Therapeutics (CYTH) Stock Price, News & Analysis

Cyclo Therapeutics logo

About Cyclo Therapeutics Stock (NASDAQ:CYTH)

Advanced Chart

Key Stats

Today's Range
$0.72
$0.72
50-Day Range
$0.72
$0.72
52-Week Range
$0.55
$1.45
Volume
N/A
Average Volume
585,177 shs
Market Capitalization
$23.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.95
Consensus Rating
Hold

Company Overview

Receive CYTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyclo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CYTH Stock News Headlines

Genesis 14:13-17 [HIDDEN MEANING?]
A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century. Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available.
10 Best Micro Cap Stocks to Buy Now
See More Headlines

CYTH Stock Analysis - Frequently Asked Questions

Cyclo Therapeutics, Inc. (NASDAQ:CYTH) issued its quarterly earnings results on Thursday, August, 15th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.14) by $0.07. The business had revenue of $0.12 million for the quarter, compared to analyst estimates of $0.40 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyclo Therapeutics investors own include Rolls-Royce Holdings PLC (RYCEY), Blink Charging (BLNK), Ford Motor (F), Alphabet (GOOG), Cassava Sciences (SAVA), Zoom Communications (ZM) and Fisker (FSR).

Company Calendar

Last Earnings
8/15/2024
Today
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CYTH
CIK
922247
Employees
9
Year Founded
N/A

Price Target and Rating

High Price Target
$0.95
Low Price Target
$0.95
Potential Upside/Downside
+31.8%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.90)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.06 million
Net Margins
-2,847.19%
Pretax Margin
-2,847.30%
Return on Equity
N/A
Return on Assets
-307.16%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.17
Quick Ratio
0.16

Sales & Book Value

Annual Sales
$870.73 thousand
Price / Sales
27.24
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.21 per share
Price / Book
3.43

Miscellaneous

Outstanding Shares
32,919,000
Free Float
23,116,000
Market Cap
$23.72 million
Optionable
No Data
Beta
-0.57

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:CYTH) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners